Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13584610

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel genetic markers associated with response of a patient with esophageal cancer (ECa) to chemoradiation therapy, and particularly to methods and kits for predicting an ECa patient's response to chemoradiation therapy by genotyping of the markers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL TAIWAN UNIVERSITY106 TAIPEI CITY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Pei-Chun Taipei City, TW 24 246
Chen, Shin-Kuang Taipei City, TW 2 0
Chen, Yen-Ching Taipei City, TW 5 24
Chuang, Eric Y Taipei City, TW 8 0
Hsiao, Chuhsing K Taipei City, TW 2 0
Lai, Liang-Chuan Taipei City, TW 25 112
Lee, Jang-Ming Taipei City, TW 4 4
Tsai, Mong-Hsun Taipei City, TW 7 0
Yang, Pei-Wen Keelung City, TW 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation